
Organometallics p. 1873 - 1877 (1983)
Update date:2022-08-04
Topics:
Streitwieser Jr., Andrew
Kluttz, Robert Q.
Smith, Kennith A.
Luke, Wayne D.
Bis(benzo[8-annulene])uranium(IV) (dibenzouranocene), 4, and the thorium analogue 5 have been prepared from benzocyclooctatetraene dianion and the metal tetrachlorides. The Diels-Alder product from cyclooctatrienyne and butadiene, 7,10-dihydrobenzocyclooctatetraene, 2, gave a uranocene derivative, 6, which could not be dehydrogenated to 4. Catalytic hydrogenation, however, did gave the uranium derivative 7 of tetrahydrobenzocyclooctatetraene. The corresponding deuterogenation gave 70% exo and 30% endo incorporation of deuterium. Reaction of cyclooctatetraene dianion with 1,4-dibromobutane gave cis-bicyclo[6.A.0]dodeca-2,4,6-triene, 8, which on deprotonation with KNH2/NH3 and treatment with UCl4 also gave 7. Analysis of NMR spectra of 4 indicates a spin density distribution closely related to that in the radical anion of benzocyclooctatetraene. The ligand exchange equilibrium between 4 and uranocene has been determined and found to favor the mixed-sandwich compound.
Contact:+86-27-67841589
Address:Add: 999 Gaoxin Road, Donghu New Technology Development Zone, Wuhan City, Hubei, China
Contact:+86-25-85281586
Address:13F,Bld2#,South of Longpan Road
BrightGene Bio-Medical Technology Co., Ltd.
website:https://en.bright-gene.com/
Contact:+86-512-62551801
Address:Building C25 - C31, No. 218 Xinghu Road, Suzhou Industrial Park, Suzhou, Jiangsu, China.
MedicalChem(Yancheng)Manuf.Co.,Ltd.
Contact:+86-515-84383366
Address:Touzeng BinHai, YanCheng City, JiangSu Province, China
Contact:+86-18200374913
Address:Hongmei Road, No. 99
Doi:10.3109/10799890903555640
(2010)Doi:10.1016/j.tet.2005.08.117
(2006)Doi:10.1016/S0040-4020(01)82422-4
(1984)Doi:10.1016/j.tetlet.2018.09.051
(2018)Doi:10.1021/ja056358i
(2006)Doi:10.1007/s00044-004-0115-6
(2004)